FDA Inspection 1322602 — Texas Children's Hospital Blood Bank
The FDA completed an inspection of Texas Children's Hospital Blood Bank on Jun 11, 2026 in Houston, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Jun 11, 2026
- Fiscal Year
- 2026
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Houston, TX (United States)